The CDC's ACIP panel voted to recommend delaying the birth dose of the hepatitis B vaccine, ending a policy that has reined ...

Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through ...

WASHINGTON — Federal vaccine advisers, through a freewheeling, and at times combative two-day meeting, recommended a major ...

Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

The complexity of developing and manufacturing, coupled with market and regulatory dynamics, has put biosimilars out of reach ...

AI use has exploded in radiology as the field struggles with staffing shortages, exacerbated by growing imaging volumes.

In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.

John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...

The future of children’s vaccines is on the agenda at today’s meeting of federal vaccine advisers, who are reviewing the ...

A panel that issues advice on U.S. vaccine policy appears prepared to vote to recommend a delay in when most babies begin to ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

At a closed-door investor conference in New York, FDA vaccines chief Vinay Prasad railed against “misleading media narratives” as backlash mounts over his push to require larger, longer studies for ...